/SGFEF

SGFEF Stock - Siegfried Holding AG

Q: What is the analyst price target for SGFEF?

Analyst price target information is not currently available for SGFEF.

Q: What is SGFEF's market cap?

Market capitalization information is not currently available for SGFEF.

Healthcare|Drug Manufacturers - Specialty & Generic|OTC

$104.61+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $115.07

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for SGFEF

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.70

52W High$1001.00

52W Low$96.50

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$1.29B	$1.27B	$1.23B	$1.10B	$845.06M
Gross Profit	$329.06M	$320.41M	$318.89M	$239.57M	$176.20M
Gross Margin	25.4%	25.2%	25.9%	21.7%	20.9%
Operating Income	$199.26M	$172.07M	$230.78M	$131.95M	$79.39M
Net Income	$160.06M	$112.77M	$156.49M	$95.60M	$60.87M
Net Margin	12.4%	8.9%	12.7%	8.7%	7.2%
EPS	$3.71	$2.66	$3.71	$2.27	$14.68

Company Overview

Siegfried Holding AG engages in the life sciences business worldwide. The company develops and produces active pharmaceutical ingredients (APIs) and intermediates, as well as finished dosage forms, including solid oral dosage forms, and sterile and aseptic filling injectables, ophthalmics, and inhalative products. It offers contract development and manufacturing services, including pharmaceutical and analytical development, process and analytical transfer, commercial manufacturing and packaging, and scale up and clinical trial material production. In addition, the company provides APIs and controlled substances focusing on anesthetics, pain treatment applications, and central nervous and respiratory diseases. Further, it licenses oral solid and sterile products; assembles registration dossiers; and offers a common technical document for various products. The company was founded in 1873 and is headquartered in Zofingen, Switzerland.

Visit Website

Earnings History & Surprises

SGFEF

Beat Rate

75%

Last 12 quarters

Avg Surprise

+622.3%

EPS vs Estimate

Beats / Misses

9/3

Last 12 quarters

Latest EPS

$1.89

Q2 2025

EPS Surprise History

Q4 21

+638.7%

$12.04vs$1.63

Q2 22

+1419.6%

$15.15vs$1.00

Q4 22

+1200.6%

$23.54vs$1.81

Q2 23

+852.6%

$14.48vs$1.52

Q2 24

+250.9%

$7.72vs$2.20

Q3 24

+981.9%

$18.50vs$1.71

Q1 25

+895.6%

$22.50vs$2.26

Q2 25

-2.6%

$1.89vs$1.94

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q1 2026	Feb 16, 2026	—	—	—	—
Q2 2025	Jun 30, 2025	$1.94	$1.89	-2.6%	✗ MISS
Q1 2025	Feb 18, 2025	$2.26	$22.50	+895.6%	✓ BEAT
Q3 2024	Aug 22, 2024	$1.71	$18.50	+981.9%	✓ BEAT
Q2 2024	Apr 18, 2024	$2.20	$7.72	+250.9%	✓ BEAT
Q2 2023	Jun 30, 2023	$1.52	$14.48	+852.6%	✓ BEAT
Q4 2022	Dec 31, 2022	$1.81	$23.54	+1200.6%	✓ BEAT
Q2 2022	Jun 30, 2022	$1.00	$15.15	+1419.6%	✓ BEAT
Q4 2021	Dec 31, 2021	$1.63	$12.04	+638.7%	✓ BEAT
Q2 2021	Jun 30, 2021	$0.86	$11.92	+1284.4%	✓ BEAT
Q4 2020	Dec 31, 2020	$12.03	$8.02	-33.3%	✗ MISS
Q2 2020	Jun 30, 2020	$7.40	$7.50	+1.4%	✓ BEAT
Q4 2019	Dec 31, 2019	$8.25	$6.39	-22.5%	✗ MISS
Q2 2019	Jun 30, 2019	—	$6.40	—	—
Q4 2018	Dec 31, 2018	—	$6.71	—	—
Q2 2018	Jun 30, 2018	—	$6.58	—	—
Q4 2017	Dec 31, 2017	—	$4.92	—	—
Q2 2017	Jun 30, 2017	—	$5.06	—	—
Q4 2016	Dec 31, 2016	—	$3.44	—	—
Q2 2016	Jun 30, 2016	—	$3.60	—	—

Frequently Asked Questions about SGFEF

What is SGFEF's current stock price?

Siegfried Holding AG (SGFEF) is currently trading at $104.61 per share. The stock has moved +0.00% today.

What is the analyst price target for SGFEF?

No analyst price targets are currently available for this stock.

What sector is Siegfried Holding AG in?

Siegfried Holding AG operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.

What is SGFEF's market cap?

Siegfried Holding AG has a market capitalization of $4.58 billion, making it a mid-cap company.

Does SGFEF pay dividends?

No, Siegfried Holding AG does not currently pay a dividend to shareholders.